Related Experiment Video
Updated: Mar 29, 2026

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin
Loris R Lopetuso, Valentina Petito, Franco Scaldaferri
1Department of Internal Medicine, Gastroenterology Division, Catholic University of Rome, Policlinico "A. Gemelli" Hospital, Roma 00168, Italia. agasbarrini@rm.unicatt.it.
Abstract:
The gastrointestinal tract is a complex and dynamic network where an intricate and mutualistic symbiosis modulates the relationship between the host and the microbiota in order to establish and ensure gut homeostasis. Every day, thousands of compounds derived from food and microorganisms come in contact with the intestinal mucosa. This interaction requires a complex defense system that separates intestinal contents from the host tissues, regulates nutrient absorption, and allows tolerance between the resident bacterial flora and the mucosal immune system, while inhibiting translocation of infectious agents to the inner tissues. Unfavorable alteration of microbiota composition has been implicated in hepatic, gastrointestinal, and perhaps also systemic disorders. In this scenario, gut microbiota modulation represents an intriguing field and can be obtained by several approaches, including antibiotics, pro- and pre-biotics supplementation. Among antibiotics, Rifaximin seems to be a promising antibiotic to treat conditions related to gut microbiota imbalance and to potentially modulate intestinal homeostasis. This review focuses on what is currently known regarding the possible role of Rifaximin in restoring normal gut immune physiology and a healthy gut-liver axis. Detailed mechanistic studies will improve the development of targeted therapies that may shape gut microflora composition with the end goal of promoting gut health.
Related Concept Videos
Functions of the Gut Microbiota
Microbiota of the Large Intestine
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Development of Human Microbiota
Probiotics
The Oral Microbiota

